What is he best known for?
The fields of study he is best known for:
Matthew Meyerson mostly deals with Cancer research, Genetics, Cancer, Mutation and Gene.
His Cancer research research is multidisciplinary, relying on both DNA methylation, Epidermal growth factor receptor, Immunology, microRNA and Lung cancer.
Genome, Carcinogenesis, Human genome, Exome and Germline mutation are the primary areas of interest in his Genetics study.
His Cancer research incorporates elements of Exome sequencing, Gene expression profiling, Somatic cell, Gene dosage and Human genetics.
His Gene expression profiling research is multidisciplinary, incorporating elements of Mesenchymal Glioblastoma, Computational biology and Bioinformatics.
His Mutation research includes elements of Genome-wide association study, Melanoma, Neuroblastoma and Kinase.
His most cited work include:
- EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. (7935 citations)
- EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. (7935 citations)
- Comprehensive molecular portraits of human breast tumours (7253 citations)
What are the main themes of his work throughout his whole career to date?
Matthew Meyerson focuses on Cancer research, Genetics, Cancer, Gene and Mutation.
His biological study spans a wide range of topics, including Epidermal growth factor receptor, Carcinogenesis, KRAS, Lung cancer and Adenocarcinoma.
His Epidermal growth factor receptor research integrates issues from Tyrosine kinase and Molecular biology.
His research in Adenocarcinoma intersects with topics in Lung and Gene expression profiling.
Genetics is represented through his Genome, Human genome, Exome, Exome sequencing and Germline mutation research.
His studies deal with areas such as Oncology, Bioinformatics and Pathology as well as Cancer.
He most often published in these fields:
- Cancer research (58.21%)
- Genetics (42.48%)
- Cancer (37.89%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (58.21%)
- Cancer (37.89%)
- Gene (25.37%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Cancer, Gene, Genetics and Computational biology.
His work carried out in the field of Cancer research brings together such families of science as Oncogene, Mutant, KRAS, Colorectal cancer and Adenocarcinoma.
The Colorectal cancer study combines topics in areas such as Carcinogenesis, Fusobacterium and Microsatellite instability.
He combines subjects such as SOS1, Lung and Gene expression profiling with his study of Adenocarcinoma.
His Cancer study incorporates themes from Cell, Kinase and Oncology.
His work deals with themes such as Genome, Human genome and Sequence analysis, which intersect with Computational biology.
Between 2016 and 2021, his most popular works were:
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer (865 citations)
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (805 citations)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (792 citations)
In his most recent research, the most cited papers focused on:
His primary scientific interests are in Cancer research, Cancer, Gene, Genetics and Mutation.
His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Colorectal cancer, microRNA and DNA methylation.
The concepts of his Cancer study are interwoven with issues in Missense mutation and Oncology.
Genetics is often connected to Drug response in his work.
His studies in Mutation integrate themes in fields like Bladder cancer, Molecular biology, Breast cancer and Promoter.
The various areas that Matthew Meyerson examines in his Adenocarcinoma study include Lung cancer and Lung.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
